Stem Cell Research (Apr 2021)

Establishment of an induced pluripotent stem cell line (ZJSHi001-A) from a patient with epileptic encephalopathy carrying KCNB1 Glu330Asp mutation

  • Yufan Guo,
  • Jianda Wang,
  • ZhiLiang Wang,
  • Yuting Lou,
  • Wangyang Chen,
  • Min Sheng,
  • Ye Wang,
  • Bijun Zhang,
  • Liuyan Gao,
  • Jianhua Feng

Journal volume & issue
Vol. 52
p. 102224

Abstract

Read online

Early infantile epileptic encephalopathy 26 (EE26) is a form of epileptic encephalopathy, a heterogeneous group of severe childhood-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. A recent study has shown that the KCNB1 gene mutation is associated with EE26; yet, the exact mechanism remains unclear. In this study, we produced an induced pluripotent stem cell line (iPSC) with a heterozygous variant of the KCNB1 gene (c.990G > T, p.Glu330Asp). Induced iPSCs were generated from peripheral blood mononuclear cells (PBMCs) obtained from a female child aged 6 with KCNB1 gene c. 990G > T and p.Glu330Asp heterozygous mutation.